Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 7.639\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) COc1ccc(CCNC(=O)c2ccc(CNc3c(N4CCOCC4)c(=O)c3=O)cc2)cc1OC
(b) CC(=O)NCCCC(=O)NNC1CC(=O)N(c2cccc(Cl)c2)C1=O
Answer: a. COc1ccc(CCNC(=O)c2ccc(CNc3c(N4CCOCC4)c(=O)c3=O)cc2)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CCNC(=O)c2ccc(CNc3c(N4CCOCC4)c(=O)c3=O)cc2)cc1OC
COc1ccc(CCNC(=O)c2ccc(CNc3c(N4CCOCC4)c(=O)c3=O)cc2)cc1OC
N-[2-(3,4-dimethoxyphenyl)ethyl]-4-[[(2-morpholin-4-yl-3,4-dioxocyclobuten-1-yl)amino]methyl]benzamide